Wed, April 12, 2023
Tue, April 11, 2023
Mon, April 10, 2023
Fri, April 7, 2023
Thu, April 6, 2023

Serge Belanger Reiterated (VRDN) at Strong Buy and Held Target at $47 on, Apr 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-47-on-apr-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Serge Belanger of Needham, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $47 on, Apr 10th, 2023.

Serge has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Serge


  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $49 on, Thursday, March 30th, 2023
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Thursday, March 9th, 2023
  • Michael Higgins of "Ladenburg Thalmann" Reiterated at Strong Buy and Held Target at $40 on, Thursday, March 9th, 2023
  • Thomas Smith of "SVB Leerink" Maintained at Buy with Increased Target to $45 on, Monday, January 9th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Friday, December 16th, 2022

Publication Contributing Sources